Micropulse Laser Trabeculoplasty (MLT) Versus Selective Laser Trabeculoplasty (SLT) for Treatment of Open Angle Glaucoma

Completed · Not applicable

Conditions studied: Open Angle Glaucoma

In brief

The purpose of this study is to evaluate the effectiveness of a new laser (called Micropulse Laser Trabeculoplasty or MLT) in the treatment of glaucoma compared to the conventional laser presently used which is called selective laser trabeculoplasty or SLT. Both lasers (SLT and MLT) are used as standard of care in the treatment of open angle glaucoma.

Key facts

Study ID

NCT01956942

Run by

David Belyea

People needed

81

Starts

2013-08-01

Expected to finish

2017-07-24

Last updated by the study team

2023-06-13

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients of any ange age
• Diagnosis of open angle glaucoma who have not had recent changes in their medication regimen.

You may not qualify if…

• Patients with active neovascularization of the angle, angle closure glaucoma, angle recession, or anterior uveitis

Where it is running

• George Washington University Medical Faculty Associates — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.